Stockreport

BioCryst's Revenue Gains Offset By Rising Expenses: A Closer Look [Seeking Alpha]

BioCryst Pharmaceuticals, Inc.  (BCRX) 
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: biocryst.gcs-web.com/investor-relations
PDF Orladeyo's revenue growth is offset by high SG&A expenses; R&D costs remain high despite discontinued programs. Financial analysis shows a challenging liquidity situa [Read more]